Teva Pharmaceutical Industries Ltd
TEVA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818686
In the last 90 days, Teva Pharmaceutical Industries Ltd insiders filed 0 open-market purchases and 8 sales; 675 institutions reported holding it in 13F filings for Q2 2026, worth $24.7B in total; 3 superinvestors hold it, including Greenlight Capital and Duquesne Family Office.
Holders of 5% or more of TEVA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Teva Pharmaceutical Industries Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. | 13G/A | 6.30%72.3M shares | +1.20 ppfrom 5.10% | Oct 6, 20252 filings | Feb 9, 2026 | SEC |
| Migdal Insurance & Financial Holdings Ltd. | 13G | 5.37%61.7M shares | New | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
| Menora Mivtachim Holdings Ltd. | 13G | 5.00%57.4M shares | New | Jul 17, 20251 filing | Jul 17, 2025 | SEC |
| Phoenix Holdings Ltd. | 13G | 5.00%57.4M shares | New | Jul 22, 20251 filing | Jul 22, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on Teva Pharmaceutical Industries Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 202611:05 AM ET | Migdal Insurance & Financial Holdings Ltd. | 13G | 5.37%61.7M shares | New | Dec 31, 2025 | SEC |
| Feb 9, 20266:03 AM ET | Harel Insurance Investments & Financial Services Ltd. | 13G/A | 6.30%72.3M shares | +1.20 ppfrom 5.10% | Dec 31, 2025 | SEC |
| Nov 5, 202511:49 AM ET | FMR LLCand 1 other | 13G/A | 2.10%24.6M shares | −3.00 ppfrom 5.10%Below 5% | Sep 30, 2025 | SEC |
| Oct 6, 20256:08 AM ET | Harel Insurance Investments & Financial Services Ltd. | 13G | 5.10%58.1M shares | New | Sep 29, 2025 | SEC |
| Aug 6, 202512:14 PM ET | FMR LLCand 1 other | 13G/A | 5.10%58.1M shares | −2.10 ppfrom 7.20% | Jun 30, 2025 | SEC |
| Jul 22, 20259:25 AM ET | Phoenix Holdings Ltd. | 13G | 5.00%57.4M shares | New | Jul 14, 2025 | SEC |
| Jul 17, 202511:57 AM ET | Menora Mivtachim Holdings Ltd. | 13G | 5.00%57.4M shares | New | Jul 16, 2025 | SEC |
| Feb 12, 20259:22 AM ET | FMR LLCand 1 other | 13G/A | 7.20%82.0M shares | – | Dec 31, 2024 | SEC |
| Jun 9, 2023 | Capital Research Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Capital Research Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Capital Research Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Capital Research Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Teva Pharmaceutical Industries Ltd shares.
No Form 144 notices for Teva Pharmaceutical Industries Ltd are on file.